| UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
|||||||
|
Kinase Fusion Gene:PRKACB_PRKACB |
Kinase Fusion Protein Summary |
 Kinase Fusion gene summary |
| Kinase Fusion partner gene information | Kinase Fusion gene name: PRKACB_PRKACB | KinaseFusionDB ID: KFG4875 | FusionGDB2.0 ID: KFG4875 | Hgene | Tgene | Gene symbol | PRKACB | PRKACB | Gene ID | 5567 | 5567 | |
| Gene name | protein kinase cAMP-activated catalytic subunit beta | protein kinase cAMP-activated catalytic subunit beta | ||||||||||
| Synonyms | CAFD2|PKA C-beta|PKACB | CAFD2|PKA C-beta|PKACB | ||||||||||
| Cytomap | 1p31.1 | 1p31.1 | ||||||||||
| Type of gene | protein-coding | protein-coding | ||||||||||
| Description | cAMP-dependent protein kinase catalytic subunit betaprotein kinase A catalytic subunit betaprotein kinase, cAMP-dependent, beta catalytic subunitprotein kinase, cAMP-dependent, catalytic, beta | cAMP-dependent protein kinase catalytic subunit betaprotein kinase A catalytic subunit betaprotein kinase, cAMP-dependent, beta catalytic subunitprotein kinase, cAMP-dependent, catalytic, beta | ||||||||||
| Modification date | 20240411 | 20240411 | ||||||||||
| UniProtAcc | P22694 | P22694 | ||||||||||
| Ensembl transtripts involved in fusion gene | ENST ids | ENST00000370680, ENST00000370682, ENST00000370685, ENST00000370688, ENST00000370689, ENST00000394838, ENST00000394839, ENST00000470673, | ENST00000370680, ENST00000370682, ENST00000370685, ENST00000370688, ENST00000370689, ENST00000394838, ENST00000394839, ENST00000470673, | |||||||||
| Context (manual curation of fusion genes in KinaseFusionDB) | PubMed: PRKACB [Title/Abstract] AND PRKACB [Title/Abstract] AND fusion [Title/Abstract] | |||||||||||
| Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | PRKACB(84579264)-PRKACB(84579412), # samples:1 | |||||||||||
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | PRKACB | GO:0006468 | protein phosphorylation | 12420224|21880142 |
| Hgene | PRKACB | GO:1904262 | negative regulation of TORC1 signaling | 31112131 |
| Tgene | PRKACB | GO:0006468 | protein phosphorylation | 12420224|21880142 |
| Tgene | PRKACB | GO:1904262 | negative regulation of TORC1 signaling | 31112131 |
| Kinase Fusion gene breakpoints across PRKACB (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Kinase Fusion gene breakpoints across PRKACB (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Kinase Fusion Gene Sample Information |
| Kinase Fusion gene information. |
| Kinase Fusion gene information from four resources (ChiTars 5.0, ChimerDB 4.0, COSMIC, and CCLE) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Sample | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp |
| ChiTaRS5.0 | AA578498 | PRKACB | chr1 | 84579264 | PRKACB | chr1 | 84579412 |
Top |
Kinase Fusion ORF Analysis |
| Kinase Fusion information from ORFfinder translation from full-length transcript sequence from KinaseFusionDB. |
| Henst | Tenst | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Seq length (transcript) | Seq length (amino acids) |
Top |
Kinase Fusion Amino Acid Sequences |
| For individual full-length fusion transcript sequence from KinaseFusionDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >Henst_Tenst_Hgene_Hchr_Hbp_Tgene_Tchr_Tbp_length(fusion AA)_AAseq |
Multiple Sequence Alignment of All Fusion Protein Isoforms |
Top |
Kinase Fusion Protein Functional Features |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:84579264/:84579412) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| PRKACB | PRKACB |
| FUNCTION: Mediates cAMP-dependent signaling triggered by receptor binding to GPCRs (PubMed:12420224, PubMed:21423175, PubMed:31112131). PKA activation regulates diverse cellular processes such as cell proliferation, the cell cycle, differentiation and regulation of microtubule dynamics, chromatin condensation and decondensation, nuclear envelope disassembly and reassembly, as well as regulation of intracellular transport mechanisms and ion flux (PubMed:12420224, PubMed:21423175). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:12420224, PubMed:21423175). Phosphorylates GPKOW which regulates its ability to bind RNA (PubMed:21880142). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). {ECO:0000269|PubMed:12420224, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21880142, ECO:0000269|PubMed:31112131}. | FUNCTION: Mediates cAMP-dependent signaling triggered by receptor binding to GPCRs (PubMed:12420224, PubMed:21423175, PubMed:31112131). PKA activation regulates diverse cellular processes such as cell proliferation, the cell cycle, differentiation and regulation of microtubule dynamics, chromatin condensation and decondensation, nuclear envelope disassembly and reassembly, as well as regulation of intracellular transport mechanisms and ion flux (PubMed:12420224, PubMed:21423175). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:12420224, PubMed:21423175). Phosphorylates GPKOW which regulates its ability to bind RNA (PubMed:21880142). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). {ECO:0000269|PubMed:12420224, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21880142, ECO:0000269|PubMed:31112131}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - Retained domain in the 5'-partner of fusion protein (protein functional feature from UniProt). |
| Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
| - Retained domain in the 3'-partner of fusion protein (protein functional feature from UniProt). |
| Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
Top |
Kinase-Substrate Information of PRKACB_PRKACB |
| Phosphorylation target of the kinase (phosphosite, 03-17-2024) |
| Kinase | Kinase UniProt Acc | Kinase species | Substrate | Substrate UniProt Acc | Substrate phosphorylated residues | Substrate phosphorylated sites (+/-7AA) | Domain |
| PRKACB | P22694 | human | AQP2 | P41181 | S256 | REVRRRQsVELHsPQ | |
| PRKACB | P22694 | human | SRSF2 | Q01130 | S121 | GyGrRSRsPRRRRRs | |
| PRKACB | P22694 | human | SRSF2 | Q01130 | S171 | RSARRsKsksSsVsR | |
| PRKACB | P22694 | human | SRSF2 | Q01130 | S128 | sPRRRRRsRsRSRSR | |
| PRKACB | P22694 | human | NGFR | P08138 | S303 | PEGEKLHsDsGIsVD | |
| PRKACB | P22694 | human | SRSF2 | Q01130 | S130 | RRRRRsRsRSRSRSR |
| Biological Network Integration of This Kinase and Substrates (GeneMANIA website) |
| Enriched GO biological processes of the phosphorylation target genes of the kinase |
| Kinase | GOID | GO term | P.adjust |
| PRKACB | ID | Description | 0.00e+00 |
| PRKACB | GO:0035907 | dorsal aorta development | 3.32e-02 |
| PRKACB | GO:0046689 | response to mercury ion | 3.32e-02 |
| PRKACB | GO:0072205 | metanephric collecting duct development | 3.32e-02 |
| PRKACB | GO:0015791 | polyol transmembrane transport | 3.32e-02 |
| PRKACB | GO:0042487 | regulation of odontogenesis of dentin-containing tooth | 3.32e-02 |
| PRKACB | GO:0009415 | response to water | 3.32e-02 |
| PRKACB | GO:0072044 | collecting duct development | 3.32e-02 |
| PRKACB | GO:0042481 | regulation of odontogenesis | 3.32e-02 |
| PRKACB | GO:0051797 | regulation of hair follicle development | 3.32e-02 |
| PRKACB | GO:0003091 | renal water homeostasis | 3.32e-02 |
| PRKACB | GO:0016048 | detection of temperature stimulus | 3.32e-02 |
| PRKACB | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway | 3.32e-02 |
| PRKACB | GO:0071280 | cellular response to copper ion | 3.32e-02 |
| PRKACB | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 3.32e-02 |
| PRKACB | GO:0042634 | regulation of hair cycle | 3.32e-02 |
| PRKACB | GO:0006833 | water transport | 3.32e-02 |
| PRKACB | GO:0099171 | presynaptic modulation of chemical synaptic transmission | 3.32e-02 |
| PRKACB | GO:0031069 | hair follicle morphogenesis | 3.32e-02 |
| PRKACB | GO:0050891 | multicellular organismal-level water homeostasis | 3.32e-02 |
| PRKACB | GO:0110110 | positive regulation of animal organ morphogenesis | 3.32e-02 |
| PRKACB | GO:0046688 | response to copper ion | 3.32e-02 |
| PRKACB | GO:0048730 | epidermis morphogenesis | 3.32e-02 |
| PRKACB | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 3.32e-02 |
| PRKACB | GO:0042044 | fluid transport | 3.32e-02 |
| PRKACB | GO:1904646 | cellular response to amyloid-beta | 3.60e-02 |
| PRKACB | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 3.82e-02 |
| PRKACB | GO:1902895 | positive regulation of miRNA transcription | 3.82e-02 |
| PRKACB | GO:0048146 | positive regulation of fibroblast proliferation | 3.82e-02 |
| PRKACB | GO:1904645 | response to amyloid-beta | 3.82e-02 |
| PRKACB | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 3.84e-02 |
| PRKACB | GO:0051289 | protein homotetramerization | 3.89e-02 |
| PRKACB | GO:2000630 | positive regulation of miRNA metabolic process | 3.89e-02 |
| PRKACB | GO:0035904 | aorta development | 3.89e-02 |
| PRKACB | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 3.89e-02 |
| PRKACB | GO:0032922 | circadian regulation of gene expression | 3.89e-02 |
| PRKACB | GO:1902893 | regulation of miRNA transcription | 3.89e-02 |
| PRKACB | GO:0061614 | miRNA transcription | 3.89e-02 |
| PRKACB | GO:0140962 | multicellular organismal-level chemical homeostasis | 3.89e-02 |
| PRKACB | GO:0001937 | negative regulation of endothelial cell proliferation | 3.89e-02 |
| PRKACB | GO:0008543 | fibroblast growth factor receptor signaling pathway | 3.89e-02 |
| PRKACB | GO:2000628 | regulation of miRNA metabolic process | 3.89e-02 |
| PRKACB | GO:0048145 | regulation of fibroblast proliferation | 3.89e-02 |
| PRKACB | GO:0051262 | protein tetramerization | 3.89e-02 |
| PRKACB | GO:0140747 | regulation of ncRNA transcription | 3.89e-02 |
| PRKACB | GO:0001942 | hair follicle development | 3.89e-02 |
| PRKACB | GO:0042475 | odontogenesis of dentin-containing tooth | 3.89e-02 |
| PRKACB | GO:1900182 | positive regulation of protein localization to nucleus | 3.89e-02 |
| PRKACB | GO:0001656 | metanephros development | 3.89e-02 |
| PRKACB | GO:0071229 | cellular response to acid chemical | 3.89e-02 |
Top |
Related Drugs to PRKACB_PRKACB |
| Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Drug | Source | PMID |
| Distribution of the number of studies mentioning PRKACB-PRKACB and kinase inhibitors the PubMed Abstract (04-01-2024) |
| Fusion gene - drug pair 1 | Fusion gene - drug pair 2 | PMID | Publication date | DOI | Study title |
Top |
Related Diseases to PRKACB_PRKACB |
| Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Disease | Source | PMID |
| Related diseases from the literature mentioned this fusion gene and drug. (PubMed, 04-01-2024) |
| MeSH ID | MeSH term |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Top |
Clinical Trials of the Found Drugs/Small Molecules |
| Statistics of the Clinical Trials of the Found Kinase Inibitors from clinicaltrials.gov (06-17-2024) |
| Clinical Trials from clinicaltrials.gov (06-17-2024) |
| Fusion Gene | Kinase Inhibitor | NCT ID | Study Status | Phases | Disease | # Enrolment | Date |
Copyright 2024-Present -The University of Texas Health Science Center at Houston
Web File Viewing | Emergency Information |Campus Carry|Site Policies |